Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ophthalmics contributes to Ciba Vision growth:

This article was originally published in Clinica

Executive Summary

Novartis, the result of the merger of Swiss companies Ciba and Sandoz, has reported results for 1996. Its ophthalmics and optics division, Ciba Vision, saw sales rise 8% to SwFr 1,206 million ($989 million). Adjusted for exchange rate moves, the rise was a slightly lower 5%, which Novartis attributed equally to ophthalmics and optics.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT084559

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel